In methods, compounds, and topical formulations for treatment of inflammatoryskin disorders incorporating compounds represented by the formulas (I, II,III) below: wherein each of R1, R2, and R3 is independently hydrogen, hologen,alkyl, or alkoxy； each of R4 and R5 is independently hydrogen, alkyl, oralkoxy； and each of R6 and R7 is independently hydrogen, nitro, alkyl, oralkoxy； wherein each of A1, A3, and A4 is independently hydrogen or alkyl； andA2 is independently hydrogen or hydroxy； and wherein each of B1, B2, and B3 isindependently hydrogen, hydroxy, or alkoxy； and each of B4 and B5 isindependently hydrogen or alkyl, applying such compounds topically as sprays,mists, aerosols, solutions, lotions, gels, creams, ointments, pastes,unguents, emulsions, and suspensions to treat inflammatory skin disorders andthe symptoms associated therewith.
